11 results
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Demyelinating Syndrome ... inflammation, leading ... APS), Secondary prevention ... Erythematosus #SLE #CNS #neurology ... #rheumatology #
Adult Vancomycin Guidelines
The information below provides general dosing guidelines for vancomycin. A maintenance regimen of 15-20
provides general dosing ... reference source and nephrology ... nephrotoxicity and acute ... #Management #Pharmacology ... #Loading #Maintenance
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
• Drug induced acute ... • Treatment includes ... prevention by minimizing ... Vancomycin #AKI #pharmacology ... diagnosis #management #nephrology
Acute Kidney Injury (AKI) in Patients with Cancer 

Cancer Related 
• Hypercalcemia 
• Intravenous contrast 
•
Acute Kidney Injury ... change disease • Hematologic ... malignancies Treatment ... cyclophosphamide) #Acute ... Classification #Nephrology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
- Summary Acute ... variants: (1) acute ... Treatment: • Plasmapheresis ... diagnosis #management #treatment ... #neurology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Torsemide) • Acute ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... Excretion #Diuresis #Nephrology ... #Pharmacology #
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
important to recognize Acute ... then be excreted using ... Cardiac cath if acute ... coronary syndrome ... icu #clinical #pharmacology
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
Cauda Equina Syndrome ... spine • MCC- acute ... bladder for urinary retention ... axial T1 and T2 Treatment ... diagnosis #causes #neurology
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Indication: Preventive ... Treatment of Migraines ... Erenumab #Migraine #Neurology ... #Pharmacology # ... Dosing
Medications Used in the Abortive Treatment of Ongoing Seizure Activity in the Emergency Department

INITIAL THERAPY
 -
in the Abortive Treatment ... SECOND-TIER TREATMENTS ... #Medications #Neurology ... #Pharmacology # ... Dosing #Table